View in EDS HTML Full Text PDF Full Text

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.

Saved in:
Bibliographic Details
Title: Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
Authors: Luetkemeyer AF; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General, University of California San Francisco, San Francisco, California, USA., Chew KW; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Lacey S; Biostatistics, Shionogi B.V., London, United Kingdom., Hughes MD; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Harrison LJ; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Daar ES; Division of HIV Medicine, Lundquist Institute at Harbor University of California Los Angeles, Torrance, California, USA., Eron J; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Fletcher CV; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA., Greninger AL; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Hessinger D; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Li JZ; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mailhot D; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Wohl D; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Chayakulkeeree M; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Mendoza JLA; Internal Medicine Department, IPS Centro Cientifico Asistencial S.A.S., Barranquilla, Colombia., Elistratova P; Clinical Development, Shionogi Inc., Florham Park, New Jersey, USA., Makinde O; Clinical Development, Shionogi Inc., Florham Park, New Jersey, USA., Morgan G; Portfolio Management, Shionogi Inc., Florham Park, New Jersey, USA., Portsmouth S; Clinical Development, Shionogi Inc., Florham Park, New Jersey, USA., Uehara T; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan., Smith D; Antiviral Research Center, University of California, San Diego, California, USA., Currier JS; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Jul 18; Vol. 80 (6), pp. 1235-1244.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39960062
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Luetkemeyer+AF%22">Luetkemeyer AF</searchLink>; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Chew+KW%22">Chew KW</searchLink>; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Lacey+S%22">Lacey S</searchLink>; Biostatistics, Shionogi B.V., London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hughes+MD%22">Hughes MD</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Harrison+LJ%22">Harrison LJ</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Daar+ES%22">Daar ES</searchLink>; Division of HIV Medicine, Lundquist Institute at Harbor University of California Los Angeles, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Eron+J%22">Eron J</searchLink>; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Fletcher+CV%22">Fletcher CV</searchLink>; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Greninger+AL%22">Greninger AL</searchLink>; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Hessinger+D%22">Hessinger D</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Li+JZ%22">Li JZ</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Mailhot+D%22">Mailhot D</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wohl+D%22">Wohl D</searchLink>; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Chayakulkeeree+M%22">Chayakulkeeree M</searchLink>; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Mendoza+JLA%22">Mendoza JLA</searchLink>; Internal Medicine Department, IPS Centro Cientifico Asistencial S.A.S., Barranquilla, Colombia.<br /><searchLink fieldCode="AU" term="%22Elistratova+P%22">Elistratova P</searchLink>; Clinical Development, Shionogi Inc., Florham Park, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Makinde+O%22">Makinde O</searchLink>; Clinical Development, Shionogi Inc., Florham Park, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+G%22">Morgan G</searchLink>; Portfolio Management, Shionogi Inc., Florham Park, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Portsmouth+S%22">Portsmouth S</searchLink>; Clinical Development, Shionogi Inc., Florham Park, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Uehara+T%22">Uehara T</searchLink>; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; Antiviral Research Center, University of California, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Currier+JS%22">Currier JS</searchLink>; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2025 Jul 18; Vol. 80 (6), pp. 1235-1244.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39960062
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciaf029
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1235
    Titles:
      – TitleFull: Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Luetkemeyer AF
      – PersonEntity:
          Name:
            NameFull: Chew KW
      – PersonEntity:
          Name:
            NameFull: Lacey S
      – PersonEntity:
          Name:
            NameFull: Hughes MD
      – PersonEntity:
          Name:
            NameFull: Harrison LJ
      – PersonEntity:
          Name:
            NameFull: Daar ES
      – PersonEntity:
          Name:
            NameFull: Eron J
      – PersonEntity:
          Name:
            NameFull: Fletcher CV
      – PersonEntity:
          Name:
            NameFull: Greninger AL
      – PersonEntity:
          Name:
            NameFull: Hessinger D
      – PersonEntity:
          Name:
            NameFull: Li JZ
      – PersonEntity:
          Name:
            NameFull: Mailhot D
      – PersonEntity:
          Name:
            NameFull: Wohl D
      – PersonEntity:
          Name:
            NameFull: Chayakulkeeree M
      – PersonEntity:
          Name:
            NameFull: Mendoza JLA
      – PersonEntity:
          Name:
            NameFull: Elistratova P
      – PersonEntity:
          Name:
            NameFull: Makinde O
      – PersonEntity:
          Name:
            NameFull: Morgan G
      – PersonEntity:
          Name:
            NameFull: Portsmouth S
      – PersonEntity:
          Name:
            NameFull: Uehara T
      – PersonEntity:
          Name:
            NameFull: Smith D
      – PersonEntity:
          Name:
            NameFull: Currier JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 07
              Text: 2025 Jul 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1